Bourgeon Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-175	Closed	-$655	–	193
2023 Q4	$655	Hold	175	–	–	﹤0.01%	349
2023 Q3	$371	Hold	175	–	–	﹤0.01%	351
2023 Q2	$833	Hold	175	–	–	﹤0.01%	308
2023 Q1	$998	Hold	175	–	–	﹤0.01%	290
2022 Q4	$1.77K	Hold	175	–	–	﹤0.01%	312
2022 Q3	$4K	Hold	175	–	–	﹤0.01%	273
2022 Q2	$4K	Hold	175	–	–	﹤0.01%	259
2022 Q1	$7K	Hold	175	–	–	﹤0.01%	241
2021 Q4	$10K	Hold	175	–	–	﹤0.01%	217
2021 Q3	$10K	Hold	175	–	–	﹤0.01%	229
2021 Q2	$15K	Hold	175	–	–	﹤0.01%	213
2021 Q1	$14K	Hold	175	–	–	﹤0.01%	215
2020 Q4	$16K	Hold	175	–	–	﹤0.01%	197
2020 Q3	$7K	Hold	175	–	–	﹤0.01%	227
2020 Q2	$6K	Hold	175	–	–	﹤0.01%	211
2020 Q1	$4K	Hold	175	–	–	﹤0.01%	223
2019 Q4	$3K	Sell	175 -825	-83%	-$13.1K	﹤0.01%	217
2019 Q3	$16K	Buy	+1,000	New	+$19.2K	0.01%	160
2014 Q3	–	Sell	-15,384	Closed	-$97K	–	106
2014 Q2	$97K	Buy	+15,384	New	+$108K	0.05%	113

Other funds holding FATE